Back to mobile site

UBS Upgrades Ionis Pharmaceuticals (IONS) to Neutral

May 7, 2021 4:11 AM EDT
Get Alerts IONS Hot Sheet
Price: $35.10 +1.77%

Rating Summary:
    8 Buy, 10 Hold, 2 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 13 | Down: 13 | New: 72
Trade Now! 
Join SI Premium – FREE

UBS analyst Esther Rajavelu upgraded Ionis Pharmaceuticals (NASDAQ: IONS) from Sell to Neutral with a price target of $37.50 (from $33.00).

For an analyst ratings summary and ratings history on Ionis Pharmaceuticals click here. For more ratings news on Ionis Pharmaceuticals click here.

Shares of Ionis Pharmaceuticals closed at $37.33 yesterday.

You May Also Be Interested In

Related Categories

Analyst PT Change, Upgrades